IGF1R and rhabdomyosarcoma: In fact, IGF1R amplification has been reported in malignant melanomas [23], breast cancers [24], pancreatic adenocarcinomas [25], gastric cell lines [26], rhabdomyosarcomas [27], Wilms' tumors [28], and gastrointestinal stromal tumors [29].